Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/06/2005WO2004092724A3 Multiple antigenic peptide assay for detection of hiv or siv type retroviruses
05/06/2005WO2004092405A3 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
05/06/2005WO2004091438B1 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers
05/06/2005WO2004090141A3 Method to increase stress tolerance in plants
05/06/2005WO2004085612A3 Metal binding proteins
05/06/2005WO2004081533A3 Vault and vault-like carrier molecules
05/06/2005WO2004080418A3 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
05/06/2005WO2004078949A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/06/2005WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids
05/06/2005WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof
05/06/2005WO2004060282A3 Uses of the snorf207 receptor
05/06/2005WO2004058815B1 Centrosome-associated protein and applications thereof
05/06/2005WO2004053086A3 Plasmodium falciparum antigens and methods of use
05/06/2005WO2004052933B1 Peptide oligomers for use as hiv vaccines
05/06/2005WO2004044220A3 Flaviviris fusion inhibitors
05/06/2005WO2004018619A3 P53 binding t cell receptor molecules and uses thereof
05/06/2005WO2004015096A8 Leech extracts for stents
05/06/2005WO2004009783A3 Truncated rgr in t cell malignancy
05/06/2005WO2003102146A3 Aptamer constructs
05/06/2005WO2003089595A3 Bivm (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof
05/06/2005WO2003076573A3 Quantitative trait loci and somatostatin
05/06/2005WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
05/06/2005WO2003018606A3 Casein derived peptides and uses thereof in therapy
05/06/2005WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
05/06/2005WO2002072787A3 Telomerase expression repressor proteins and methods of using the same
05/06/2005CA2544099A1 Peptides with anti-obesity activity and other related uses
05/06/2005CA2543360A1 Ldl receptor class a and egf domain monomers and multimers
05/06/2005CA2543329A1 Orthogonal gene switches
05/06/2005CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/06/2005CA2543189A1 In vivo gene therapy of parkinson's disease
05/06/2005CA2543095A1 Virally-safe factor viii with a low content of higher multimers
05/06/2005CA2542924A1 Msp-3-like family of genes
05/06/2005CA2542922A1 Protein expression
05/06/2005CA2542686A1 Colorectal cancer antigen
05/06/2005CA2542221A1 Vaccine for periodontal disease
05/06/2005CA2542175A1 Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses
05/06/2005CA2541840A1 P185neu-encoding dna and therapeutical uses thereof
05/06/2005CA2541523A1 Minimal dna sequence acting as a chromatin insulator and its use in protein expression
05/06/2005CA2541511A1 Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein
05/06/2005CA2541506A1 Immunogenic compostion and method of developing a vaccine based on psoralen inactivated hiv
05/06/2005CA2541501A1 Immunogenic composition and method of developing a vaccine based on factor h binding sites
05/06/2005CA2541497A1 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site
05/06/2005CA2541492A1 Immunogenic composition and method of developing a vaccine based on fusion protein
05/06/2005CA2541280A1 Modified cdna for high expression levels of factor viii and its derivatives
05/06/2005CA2540810A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use
05/06/2005CA2534828A1 Novel cxcl8 antagonists
05/05/2005US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants
05/05/2005US20050097637 Transgenic plants compromising nucleic acid molecules encoding RAR 1 disease resistance proteins and uses thereof
05/05/2005US20050097635 Nucleotide sequences coding crystal protein for use in generating insect resistant crop plants; biological pest control
05/05/2005US20050097632 Phenotype modifying genetic sequences
05/05/2005US20050097631 Transgenic plants
05/05/2005US20050097626 Tumor suppressor gene, p28ing5
05/05/2005US20050096462 Novel human neurexin-like proteins and polynucleotides encoding the same
05/05/2005US20050096461 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine
05/05/2005US20050096460 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
05/05/2005US20050096459 Oligomeric receptor ligand pair member complexes
05/05/2005US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics
05/05/2005US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss
05/05/2005US20050096339 for alleviating immune-cell mediated tissue destruction associated with the inflammatory response
05/05/2005US20050096288 Antigen specific immune response by providing low density lipoprotein and a nucleic acid to be expressed as antigen bonded to each other for genes in vaccines
05/05/2005US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
05/05/2005US20050096283 Contraceptives for mammals with nucleic acid
05/05/2005US20050096277 Methods of prevention and treatment using apolipoprotein analogues
05/05/2005US20050096275 Therapy for cell proliferative disorders or skin and other tissue; administering polypeptides
05/05/2005US20050096274 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
05/05/2005US20050096273 Regulation of matrix metalloproteinases by PSP94 family members
05/05/2005US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents
05/05/2005US20050096270 I-superfamily conotoxins
05/05/2005US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
05/05/2005US20050096267 Fusion protein contains amino acid sequence with 9 to 13 residues of arginine; antagonist of Nuclear Factor Activated T cell (NFAT); short effectiveness and no side effects or antigenicity; signal sequence, immunosuppressants, biodrugs
05/05/2005US20050096265 Characterization of a membrane estrogen receptor
05/05/2005US20050096264 Methods for treating obesity and related conditions with glycoprotein hormone beta family hormones
05/05/2005US20050096260 Metal complex-protein composite and oxidation catalyst
05/05/2005US20050096255 Methods of modulating activity of DXR
05/05/2005US20050095701 Transplanting conditionally-immortalized dorsal root ganglion progenitor cells into mammal to generate peripheral nervous system (PNS) for treatment and prevention of nervous system disorders
05/05/2005US20050095687 Process for the preparation of L-amino acids using strains of the family enterobacteriaceae
05/05/2005US20050095685 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
05/05/2005US20050095684 Protein fusion comprising colony stimulating factor activity for use as tool in rapid stimulation and production of white blood cells and neutrophils
05/05/2005US20050095682 Campylobacter polypeptides and methods of use
05/05/2005US20050095681 Intracellular modulators of apoptopic cell death pathways
05/05/2005US20050095678 Novel rat calcium channel subunits and related probes, cell lines and methods
05/05/2005US20050095677 Novel human LXRalpha variants
05/05/2005US20050095676 Novel glycoproteins and methods of use thereof
05/05/2005US20050095675 Mucin peptide with immunoenhancing properties
05/05/2005US20050095674 Cannabinoid receptor interacting proteins and methods of use
05/05/2005US20050095673 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
05/05/2005US20050095672 Recombinant IGF expression systems
05/05/2005US20050095671 Nucleotide sequences coding splice variant of ubiquination regulatory protein for use in prevention and treatment of neurodegenerative disorders
05/05/2005US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
05/05/2005US20050095662 Protein S functional assay
05/05/2005US20050095651 Via intein fragments; solid phase synthesis; immobilization; photolithography
05/05/2005US20050095650 screening for an agent that modulates capsaicin receptor function
05/05/2005US20050095633 Novel regulators of fungal gene expression
05/05/2005US20050095632 Dna encoding human binding protein; genomes; gene expression
05/05/2005US20050095631 Methods for differentiating and monitoring parathyroid and bone status related diseases
05/05/2005US20050095618 Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS)
05/05/2005US20050095617 Nucleotide sequences coding g protein coupled receptors for use in disease diagnostics and treatment, drug screening, clinical trial monitoring and enhancing cosmetics and/or nutraceutical
05/05/2005US20050095613 Molecules of the CARD-related protein family and uses thereof
05/05/2005US20050095612 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents
05/05/2005US20050095607 Breast cancer signatures
1 ... 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 ... 2916